United States · FDA National Drug Code directory
RETEVMO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0002-2980_7481a510-805c-4f99-b6ae-7b44e70f5f55
- Product NDC
- 0002-2980
- Form
- CAPSULE
- Composition / generic term
- selpercatinib
- Labeler
- Eli Lilly and Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200508
- Source listing expiry
- 20271231
Source-listed ingredients
- SELPERCATINIB — 80 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE in 1 BOTTLE (0002-2980-26) · 0002-2980-26
- 60 CAPSULE in 1 BOTTLE (0002-2980-60) · 0002-2980-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →